Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clara Cuéllar
Observed names:
C. Cuellar,
C. Cuéllar,
Clara Cuellar,
Clara cuellar,
Cuellar, C.
Institutions:
Universidad Complutense de Madrid,
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
Observed institutions:
Universidad Complutense de Madrid,
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre,
Hospital Universitario Fundación Jiménez Díaz,
Centro de Investigación Biomédica en Red de Cáncer
show all 6
ORCID:
0000-0002-4487-0070
Observed ORCID:
0000-0002-4487-0070
OpenAlex ID:
A5015087664
Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies
2020
·
José María Sanchez‐Pina
, Mario Rodríguez Rodriguez
, et al.
·
European Journal Of Haematology
·
98
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
2023
·
Alba Rodríguez-García
, Andrés Arroyo
, et al.
·
Clinical Cancer Research
·
74
PDF
Impact of COVID-19 in patients with multiple myeloma based on a global data network
2021
·
J. Martinez-Lopez
, G. Hernandez-Ibarburu
, et al.
·
Blood Cancer Journal
·
54
PDF
The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
2020
·
Maria-Teresa Cedena
, Estela Martin-Clavero
, et al.
·
PLoS ONE
·
29
PDF
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
2022
·
Adrián Alegre
, Gonzalo Benzo
, et al.
·
Oncology and Therapy
·
17
PDF
Role of light chain clearance in the recovery of renal function in multiple myeloma: another point of view
2023
·
Natàlia Ramos Terrades
, Alicia Senin
, et al.
·
Clinical Kidney Journal
·
13
PDF
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
2020
·
Carolina Villegas
, María Poza
, et al.
·
Annals of Hematology
·
10
PDF
Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience
2021
·
Adrian Alegre
, Gonzalo Benzo Callejo
, et al.
·
Blood
·
6
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT
2021
·
Malgorzata Mikulska
, Nina Knelange
, et al.
·
Journal of Infection
·
6
Large Scale Analysis of Autologous Stem Cell Transplantation for Multiple Myeloma Patients Older Than 65 Years
2023
·
Adolfo Jesús Sáez Marín
, Gema Hernández-Ibarburu
, et al.
·
Blood
·
2
P-113: Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma
2022
·
Adolfo Saez
, Nieves Lopez-Muñoz
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Supplementary Data 1 from Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
2024
·
Alba Rodríguez-García
, Andrés Arroyo
, et al.
·
1
Clinical Course and Risk Factors for Mortality from COVID-19 in Patients with Hematological Malignancies
2020
·
José María Sanchez-Pina
, Mario Rodríguez Rodriguez
, et al.
·
SSRN Electronic Journal
·
1
Supplementary Data 1 from Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
2024
·
Alba Rodríguez-García
, Andrés Arroyo
, et al.
Data from Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
2024
·
Alba Rodríguez-García
, Andrés Arroyo
, et al.
P-356 Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
2023
·
Irene Zamanillo
, Lucia Medina de Alba
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-062 Real-world evidence of bisphosphonates and denosumab for multiple myeloma
2023
·
Nieves Lopez-Munoz
, Gema Hernandez-Ibarburu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-473 Real-world evidence of statins and oral antidiabetics for multiple myeloma
2023
·
Nieves Lopez-Munoz
, Gema Hernandez-Ibarburu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P948: Real-world Evidence of Bisphosphonates for Multiple Myeloma
2023
·
Maria Nieves Lopez Muñoz
, Gema Hernández
, et al.
·
HemaSphere
Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
2023
·
N. Lopez-Muñoz
, G. Hernández-Ibarburu
, et al.
·
Journal of Hematology & Oncology
PDF
P869: Production by Gut Microbiota as Prognostic Biomarker in Mm
2022
·
A. Rodríguez-García
, R. Garcia-Vicente
, et al.
·
HemaSphere
P-148: Real-life analysis of the multiple myeloma patient’s survival in a third-level hospital
2021
·
Nieves López-Muñoz
, Rodrigo Íñiguez García
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
T cell exhaustion profile (CD4+/CD28- CD8+/CD28-) in stem cell transplantation (SCT) and respiratory viral infection (RVI). Clinicoepidemiological findings.
2018
·
Miguel Villanueva
, Angela Figuera
, et al.
·
IBJ Plus
Show more works
View as search
Works count:
29
Citation count:
330
H-index:
8
I10-index:
8
Year
Topic
Type